Can too much vitamin C cause heart problems?

For most healthy adults, the strongest evidence says no: in the largest trial of vitamin C on its own, 14,641 men were given 500 mg of vitamin C a day or a placebo for 8 years, and vitamin C made no difference to heart attacks, strokes or cardiovascular deaths.

So can too much vitamin C cause heart problems? For four groups, the picture is less settled, and one of them includes people with an inherited iron-storage condition.

Here's what the trials show, where the worry started, who those groups are, and what changes if your vitamin C is liposomal.

Table of Contents

• 1. Can Too Much Vitamin C Cause Heart Problems? What the Biggest Trials Found
• 2. Where the Heart Worry Comes From
• 3. Iron Overload: The Clearest Real Risk
• 4. If You Already Have Heart Disease or Take Heart Medication
• 5. Why the 2,000 mg Upper Limit Isn't a Heart Limit
• 6. Does Liposomal Vitamin C Change the Picture?
• 7. When to Check With a Doctor First
• Bio Absorb Liposomal Vitamin C — Absorption Without the Megadose
• Frequently Asked Questions
• Conclusion
• Research References

1. Can Too Much Vitamin C Cause Heart Problems? What the Biggest Trials Found

The strongest evidence comes from randomized trials, where chance decides who gets vitamin C and who gets a placebo. In the Physicians' Health Study II, 14,641 US male doctors aged 50 and over took 500 mg of vitamin C or a placebo every day for an average of 8 years, and the risk of major cardiovascular events was essentially identical in both groups (hazard ratio 0.99, where 1.0 means no difference).

Women show the same pattern. The Women's Antioxidant Cardiovascular Study followed 8,171 women aged 40 and over who already had cardiovascular disease or at least 3 risk factors, and 500 mg of vitamin C a day for an average of 9.4 years made no overall difference to heart attacks, strokes, coronary procedures or cardiovascular deaths (relative risk 1.02).

When Cochrane reviewers gathered the evidence in 2017, they found 8 trials with 15,445 participants, but just one of them, the 14,641-person physician study, reported actual heart events. Their verdict cuts both ways: no sign that vitamin C prevents cardiovascular disease, no sign of added risk, and a caution that the outcome data come from a single trial of middle-aged and older American men.

2. Where the Heart Worry Comes From

Most of the concern traces to observational studies, which track people's habits over time instead of assigning a treatment. Here are 3 large ones, and they point in different directions:

• Iowa Women's Health Study: among 1,923 postmenopausal women with diabetes followed for 15 years, those with the highest vitamin C intake had a relative risk of dying from cardiovascular disease of 1.84, or about 84% higher than the lowest-intake group.
• Los Angeles Atherosclerosis Study: among 573 healthy adults aged 40 to 60 followed for 3 years, the carotid artery wall thickened faster as supplement doses rose, with the top group taking 857 to 5,000 mg a day.
• A pooled analysis of 9 cohorts: across 293,172 people, those taking at least 700 mg of supplemental vitamin C a day had a 25% lower risk of coronary heart disease than people taking none.

The first two findings come with caveats. NIH notes that the Iowa link appeared with supplements of 300 mg a day or more, came from a subgroup, has no clear mechanism, and hasn't been seen in any other epidemiological study. In the Los Angeles study, vitamin C from food went the other way, with slower thickening, and the authors concluded that supplements weren't advisable for preventing atherosclerosis, the plaque build-up that narrows arteries.

Randomized trials carry more weight, because they remove the differences between people who choose supplements and people who don't. NIH cites a 2006 meta-analysis of randomized trials that found antioxidant supplements didn't change how fast atherosclerosis progresses, and the 2 large heart trials in Section 1 found no rise in cardiovascular events. So the fair summary is a real but unconfirmed signal, not an established harm.

3. Iron Overload: The Clearest Real Risk

Hereditary haemochromatosis is an inherited condition in which the body absorbs too much iron and struggles to get rid of it, and it affects 1 to 2 in every 500 people of European descent. NIH notes that vitamin C improves absorption of the non-heme iron in plant foods, and that in hereditary haemochromatosis, chronic high doses could worsen iron overload and damage tissue.

The heart is one of the places that damage shows up. A 2021 cardiology review describes iron building up in heart muscle over years, first stiffening and thickening it, then leaving it enlarged and weakened, and eventually causing heart failure with a poor outlook once it develops.

The research has a gap here. A 1999 review found that high vitamin C intakes don't upset iron balance in healthy people or, probably, in people with one copy of the gene, but the effect in people with two copies had not been studied. It advised them to keep vitamin C to about one recommended daily allowance, which today is 75 mg a day for women and 90 mg for men. Our guide to how vitamin C and iron absorption work together covers the pairing in more depth.

4. If You Already Have Heart Disease or Take Heart Medication

The most concerning trial result comes from people who already had coronary artery disease. In the WAVE trial, 423 postmenopausal women with narrowed coronary arteries took 500 mg of vitamin C plus 400 IU of vitamin E twice a day or a placebo, and 16 women died in the vitamin group compared with 6 on placebo. The vitamins didn't slow the narrowing itself, either.

Two cautions apply before reading that as a verdict on vitamin C. The women took vitamin C and vitamin E together, so the trial can't separate their effects, and the number of deaths was small. What the trial does show is that a high-dose combination brought no heart benefit to women who already had coronary disease.

Medication matters too. In the HATS trial, which followed 160 people with coronary disease and low HDL cholesterol for 3 years, adding an antioxidant mix that included vitamin C blunted the rise in a protective form of HDL that simvastatin plus niacin produced. NIH advises that health care providers monitor cholesterol levels in people who take statins with antioxidant supplements, and our guide to vitamin C interactions with medications and supplements covers other common drug pairings.

5. Why the 2,000 mg Upper Limit Isn't a Heart Limit

The Institute of Medicine set the adult upper limit at 2,000 mg a day, based on osmotic diarrhoea and other digestive problems, which happen when unabsorbed vitamin C pulls water into the gut. Our guide to vitamin C side effects and the upper limit covers those digestive effects in more depth, and a limit built on digestive comfort says little either way about the heart.

The body also caps how much vitamin C reaches your blood. NIH's figures show a steep drop-off: about 70% to 90% is absorbed at intakes of 30 to 180 mg a day, less than 50% above 1 g a day, and even 3 g every 4 hours is predicted to peak at just 220 micromoles per litre in the blood, with the surplus leaving in urine.

That tight control cuts both ways for the research. NIH points out that when trial volunteers are already near saturation, supplements would be expected to make little or no difference to outcomes, which is part of why heart trials at 500 mg a day found nothing in either direction. For the history of pushing far past that level, see our piece on high-dose vitamin C, megadosing and Pauling.

6. Does Liposomal Vitamin C Change the Picture?

Liposomal vitamin C wraps the vitamin in microscopic spheres made of phospholipids, the same fats that form cell membranes. A 2025 scoping review found that 9 of 10 studies showed higher blood levels with liposomal forms, with 1.3 to 7.2 times the total blood exposure of standard vitamin C. That absorption advantage is well documented, and our complete guide to liposomal vitamin C explains how it works.

Here's the part most articles skip. The big heart trials used standard vitamin C, and the ceiling described in Section 5 is part of why they found so little. Liposomal delivery is designed to get around the absorption part of that ceiling, and we're not aware of any trial that has tested what it does to heart outcomes, in either direction.

Regulators have noticed the broader issue. In a 2025 report, the UK's Committee on Toxicity noted that for supplements designed to increase absorption, uncertainty about how much they increase it makes their potential for adverse effects just as uncertain, particularly for vulnerable groups. The committee also pointed out that vitamin C is a special case, because the body regulates it closely, though a new formulation may change how that regulation works.

In practice, better absorption is a reason to get more from a modest dose, not a reason to take more. If you're in one of the groups in Section 7, don't assume the reassurance from trials of standard vitamin C carries over automatically, and check with your doctor before starting any form, liposomal included.

7. When to Check With a Doctor First

So can too much vitamin C cause heart problems for you? For most healthy adults, the heart trials at 500 mg a day are reassuring, and the Cochrane review found no difference in major cardiovascular events, though its heart-event data come from a single trial. It's worth talking to your doctor before you supplement if any of these apply:

• You have haemochromatosis or another iron-overload condition. Vitamin C increases iron absorption, and the 1999 review in Section 3 advised limiting intake to about one recommended daily allowance if you have two copies of the gene.
• You have coronary artery disease. The high-dose vitamin C and E combination covered in Section 4 brought no benefit and more deaths in a small trial.
• You take a statin with niacin, or another cholesterol medication. An antioxidant mix including vitamin C blunted a protective HDL response in the trial covered in Section 4.
• You're a woman past menopause with diabetes and take 300 mg a day or more. The Iowa signal is unconfirmed, but it's the group where an observational study linked supplements to higher cardiovascular death.

The same applies if you have kidney disease. NIH notes that high intakes can raise urinary oxalate, which could contribute to kidney stones, especially in people with kidney disorders, and that the 2,000 mg limit covers food and supplements combined, so bring your full supplement list, including multivitamins, to the appointment.

Bio Absorb Liposomal Vitamin C — Absorption Without the Megadose

Bio Absorb Nutraceuticals makes liposomal vitamin C, so it's fair to ask where we stand after everything above, including the parts that don't flatter the category. Our view: the research supports liposomal delivery for absorption, with 1.3 to 7.2 times the blood exposure of standard vitamin C across 9 of 10 studies, and that makes it a way to get more from a modest dose, not a licence to take more.

Our Liposomal Vitamin C Liquid 1000mg (Corn-Free) wraps vitamin C in phospholipids, has a natural orange flavour and mixes with water or juice, which suits people who like to adjust their amount. There's also a capsule version for people who want no taste, no refrigeration and easy travel, so the choice comes down to how you like to take it. Both formats are verified corn-free, non-GMO, gluten-free, nut-free, dairy-free and vegan, made in a GMP-certified Canadian facility, third-party tested every batch, and backed by a money-back guarantee.

One point we'd rather state plainly: if you're in any of the groups in Section 7, especially if you have haemochromatosis or coronary artery disease, talk to your doctor before starting any vitamin C supplement, ours included. If that's not you, you can see current pricing and serving details on the product page.

Frequently Asked Questions

Can too much vitamin C cause heart problems in healthy people?

The trial evidence says it's unlikely. The largest trial found no rise in major cardiovascular events at 500 mg a day over 8 years, and one observational link between higher doses and artery thickening hasn't been confirmed in randomized trials. Staying close to what was tested means modest doses, not megadoses.

Can vitamin C raise your blood pressure?

Not according to the trials. A meta-analysis of 29 trials found that a median of 500 mg a day for 8 weeks lowered systolic blood pressure by 3.84 mm Hg on average, though the trials were small and short, with widely varying results. It isn't a replacement for blood pressure treatment.

Does vitamin C clog your arteries?

The randomized evidence doesn't show that it does. One observational study found faster artery-wall thickening as supplement doses rose, but NIH cites a 2006 meta-analysis of randomized trials in which antioxidant supplements didn't change atherosclerosis progression. Treat it as an unconfirmed signal.

Can I take vitamin C with a statin?

Talk to your doctor before combining them. In a 3-year trial, an antioxidant mix that included vitamin C blunted a protective HDL effect of simvastatin plus niacin, and it isn't known whether other cholesterol drugs are affected.

Is vitamin C safe if you have haemochromatosis?

That's a question for your specialist, but the evidence leans toward caution. NIH warns that chronic high doses of vitamin C could worsen iron overload in hereditary haemochromatosis, and a 1999 review advised limiting it to about one RDA.

Is liposomal vitamin C safe for your heart?

For most healthy adults at modest doses there's no known heart risk, but we're not aware of any heart-outcome trial that has tested it. It produces 1.3 to 7.2 times the blood exposure of standard vitamin C, so the reassurance from the big trials doesn't automatically transfer, and anyone in an at-risk group is wise to check with a doctor first.

Conclusion

Can too much vitamin C cause heart problems? For most healthy adults, the trials say no: 500 mg a day for 8 years left heart outcomes unchanged in the largest trial of vitamin C on its own. People with haemochromatosis, coronary artery disease or a statin-niacin prescription have good reason to check with a doctor first, and if you do supplement, a modest dose of a well-absorbed, third-party-tested form like Bio Absorb's Liposomal Vitamin C Liquid makes more sense than chasing the upper limit.

Research References

1. Vitamins E and C in the Prevention of Cardiovascular Disease in Men: The Physicians' Health Study II Randomized Controlled Trial. JAMA, Vol. 300 (2008). Found that 500 mg of vitamin C daily for 8 years had no effect on major cardiovascular events in 14,641 men.
2. A Randomized Factorial Trial of Vitamins C and E and Beta Carotene in the Secondary Prevention of Cardiovascular Events in Women: Results From the Women's Antioxidant Cardiovascular Study. Archives of Internal Medicine, Vol. 167 (2007). Found no overall effect of 500 mg of vitamin C daily on cardiovascular events in 8,171 women at increased risk.
3. Effects of Hormone Replacement Therapy and Antioxidant Vitamin Supplements on Coronary Atherosclerosis in Postmenopausal Women: A Randomized Controlled Trial. JAMA, Vol. 288 (2002). Found no benefit from vitamins C and E in 423 women with coronary disease, with 16 deaths on vitamins versus 6 on placebo.
4. Does Supplemental Vitamin C Increase Cardiovascular Disease Risk in Women With Diabetes? American Journal of Clinical Nutrition, Vol. 80 (2004). Reported a relative risk of cardiovascular death of 1.84 at the highest vitamin C intakes in 1,923 women with diabetes.
5. Simvastatin and Niacin, Antioxidant Vitamins, or the Combination for the Prevention of Coronary Disease. New England Journal of Medicine, Vol. 345 (2001). Found that antioxidants blunted a protective HDL response to simvastatin plus niacin in 160 patients with coronary disease.
6. Vitamin C Supplementation for the Primary Prevention of Cardiovascular Disease. Cochrane Database of Systematic Reviews, Issue 3 (2017). Reviewed 8 trials with 15,445 participants and found no evidence that vitamin C lowers cardiovascular risk, with heart-event data from 1 trial.
7. Differing Relations to Early Atherosclerosis between Vitamin C from Supplements vs. Food in the Los Angeles Atherosclerosis Study: A Prospective Cohort Study. The Open Cardiovascular Medicine Journal, Vol. 6 (2012). Linked higher supplement doses to faster carotid artery thickening in 573 adults, and vitamin C from food to slower thickening.
8. Do Liposomal Vitamin C Formulations Have Improved Bioavailability? A Scoping Review Identifying Future Research Directions. Basic & Clinical Pharmacology & Toxicology, Vol. 137 (2025). Found higher bioavailability for liposomal vitamin C in 9 of 10 studies, with 1.3 to 7.2 times higher AUC.
9. High-dose Vitamin C: A Risk for Persons with High Iron Stores? International Journal for Vitamin and Nutrition Research, Vol. 69 (1999). Found no iron imbalance from high intakes in healthy people, noted that homozygous haemochromatosis was unstudied, and advised those patients to keep intake to about one RDA.
10. Pathogenesis, Diagnosis, and Clinical Implications of Hereditary Hemochromatosis—The Cardiological Point of View. Diagnostics, Vol. 11 (2021). Describes haemochromatosis in 1 to 2 of every 500 people of European descent and how cardiac iron overload can progress to heart failure.
11. Effects of Vitamin C Supplementation on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials. American Journal of Clinical Nutrition, Vol. 95 (2012). Found that vitamin C lowered systolic blood pressure by 3.84 mm Hg on average across 29 short-term trials.
12. Vitamin C: Fact Sheet for Health Professionals. National Institutes of Health — Office of Dietary Supplements (2025). Covers absorption, the haemochromatosis caution, the statin interaction and the limits of the Iowa finding.
13. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Institute of Medicine, National Academies Press (2000). Set the adult upper limit at 2 g a day, based on osmotic diarrhoea and gastrointestinal disturbances.
14. Novel Formulations of Supplement Compounds Designed to Increase Oral Bioavailability (COT Science Report 01/25). UK Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment (2025). Notes that uncertainty about how much these formulations raise absorption makes their potential adverse effects similarly uncertain, especially for vulnerable groups.

About the Author

David Kimbell is a health writer, digital entrepreneur and former aerospace engineer, based in Ottawa, Canada. He loves translating complex science into clear, actionable guidance for consumers seeking evidence-based solutions.

---

Important Disclaimers

Medical Disclaimer: This article provides educational information only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement, especially if you have existing health conditions, take medications, or are pregnant or nursing.

FDA/Health Canada Statement: These statements have not been evaluated by the Food and Drug Administration or Health Canada. This product is not intended to diagnose, treat, cure, or prevent any disease.